Difficulty: Medium
Average Score: 85%
Practice
The neurotransmitter system in the brain most affected in Alzheimer's disease is
Correct answer
D
Rationale
In Alzheimer's disease, the neurotransmitter system most affected is the cholinergic system. This is because Alzheimer's is characterized by a progressive loss of cholinergic neurons, leading to a decrease in acetylcholine levels in the brain. Acetylcholine is involved in memory, learning, and cognitive functions, which are significantly impaired in individuals with Alzheimer's.
Option A) Glutaminergic: This is not the correct answer because glutamate is the main excitatory neurotransmitter in the brain and is not primarily affected in Alzheimer's disease.
Option B) Gabaergic: GABA is the main inhibitory neurotransmitter in the brain and is not the primary system affected in Alzheimer's disease.
Option C) Dopaminergic: Dopamine is involved in regulating mood, movement, and reward, but it is not the neurotransmitter most affected in Alzheimer's disease.
Educational context: Understanding the neurotransmitter systems affected in Alzheimer's disease is crucial for healthcare professionals in diagnosing and treating patients with this condition. Knowing the role of the cholinergic system in memory and cognitive function helps in developing appropriate interventions to manage the symptoms of Alzheimer's disease. It also highlights the importance of research into treatments that target the cholinergic system to improve outcomes for individuals with Alzheimer's.
Option A) Glutaminergic: This is not the correct answer because glutamate is the main excitatory neurotransmitter in the brain and is not primarily affected in Alzheimer's disease.
Option B) Gabaergic: GABA is the main inhibitory neurotransmitter in the brain and is not the primary system affected in Alzheimer's disease.
Option C) Dopaminergic: Dopamine is involved in regulating mood, movement, and reward, but it is not the neurotransmitter most affected in Alzheimer's disease.
Educational context: Understanding the neurotransmitter systems affected in Alzheimer's disease is crucial for healthcare professionals in diagnosing and treating patients with this condition. Knowing the role of the cholinergic system in memory and cognitive function helps in developing appropriate interventions to manage the symptoms of Alzheimer's disease. It also highlights the importance of research into treatments that target the cholinergic system to improve outcomes for individuals with Alzheimer's.